Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic

Chi-Sheng Hung1, Chia-Hung Chou, Xue-Ming Wu

  • 1aGraduate Institute of Clinical Medicine, College of Medicine, National Taiwan University bDepartment of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine cDepartment of Obstetrics and Gynecology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei dDepartment of Internal Medicine, Taoyuan General Hospital, Taoyuan eDivision of Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City fDepartment of Internal Medicine, Postal Hospital, Taipei gDepartment of Urology, Buddhist Tzu Chi General Hospital, New Taipei City hInstitute of Pharmacology, National Taiwan University Medical College, Taipei, Taiwan.

Insights

Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) is linked to aldosterone-induced diastolic dysfunction. This cardiac condition is reversible with adrenalectomy, and TIMP-1 levels decrease post-surgery.

Area of Science:

  • Cardiology
  • Endocrinology
  • Biomarker Research

Background:

  • Primary aldosteronism causes cardiac remodeling and diastolic dysfunction, but reversibility is unclear.
  • No specific biomarkers are known for aldosterone-induced diastolic dysfunction.

Purpose of the Study:

  • To investigate the association between collagen markers and aldosterone-induced diastolic dysfunction.
  • To assess the role of TIMP-1 and MMP-2 as potential biomarkers.

Main Methods:

  • 27 patients with aldosterone-producing adenoma (APA) and 27 with essential hypertension were studied.
  • Plasma levels of TIMP-1 and MMP-2 were measured, alongside echocardiography.
  • Measurements were repeated 1 year after adrenalectomy in the APA group.

Main Results:

  • Patients with APA had higher baseline TIMP-1 levels, left ventricular mass index (LVMI), and E/E' ratio.
  • TIMP-1 levels correlated with diastolic dysfunction and cardiac remodeling markers.
  • Adrenalectomy improved LVMI and E/E' ratio, with a decrease in TIMP-1 levels.

Conclusions:

  • Excess aldosterone causes reversible diastolic dysfunction, treatable by adrenalectomy.
  • TIMP-1 is associated with aldosterone-induced diastolic dysfunction and may serve as a biomarker.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.8K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.9K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.7K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.1K
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.2K